Group a streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010

Emerging Infectious Diseases

Volumn 17, Issue 11, 2011, Pages 2010-2017

  Shea, Patrick R ^a   Ewbank, Amy L ^a   Gonzalez Lugo, Javier H ^a   Martagon Rosado, Alexandro J ^a   Martinez Gutierrez, Juan C ^a   Rehman, Hina A ^a   Serrano Gonzalez, Monica ^a   Fittipaldi, Nahuel ^a   Beres, Stephen B ^a   Flores, Anthony R ^a,b,c   Low, Donald E ^d,e,f   Willey, Barbara M ^d   Musser, James M ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b Texas Children's Hospital   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; EMM GENE; GENE FREQUENCY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; NONHUMAN; PHARYNGITIS; STREPTOCOCCUS GROUP A;

EID: 84930473759     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1711.110159     Document Type: Article

References (33)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-94. doi:10.1016/S1473-3099(05)70267-X
2. Pfoh E, Wessels MR, Goldmann D, Lee GM. Burden and economic cost of group A streptococcal pharyngitis. Pediatrics. 2008;121:229-34. doi:10.1542/peds.2007-0484
3. Lancefield RC. The antigenic complex of Streptococcus haemo-lyticus: I. Demonstration of a type-specifi c substance in extracts of Streptococcus haemolyticus. J Exp Med. 1928;47:91-103. doi:10.1084/jem.47.1.91
4. Scott JR, Pulliam WM, Hollingshead SK, Fischetti VA. Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A. 1985;82:1822-6. doi:10.1073/pnas.82.6.1822
5. Dochez AR, Avery OT, Lancefield RC. Studies on the biology of Streptococcus: I. antigenic relationships between strains of Streptococcus haemolyticus. J Exp Med. 1919;30:179-213. doi:10.1084/ jem.30.3.179
6. Lancefield RC. Persistence of type-specifi c antibodies in man following infection with group A streptococci. J Exp Med. 1959;110:271-92. doi:10.1084/jem.110.2.271
7. Manjula BN, Acharya AS, Fairwell T, Fischetti VA. Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identifi cation of a hyper-variable region of the M molecule. J Exp Med. 1986;163:129-38. doi:10.1084/jem.163.1.129
8. Shulman ST, Tanz RR, Dale JB, Beall B, Kabat W, Kabat K, et al. Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin Infect Dis. 2009;49:78-84. doi:10.1086/599344
9. Shulman ST, Tanz RR, Kabat W, Kabat K, Cederlund E, Patel D, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis. 2004;39:325-32. doi:10.1086/421949
10. Bisno AL, Rubin FA, Cleary PP, Dale JB. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles-report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis. 2005;41:1150-6. doi:10.1086/444505
11. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Im-munogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70:2171-7. doi:10.1128/IAI.70.4.2171-2177.2002
12. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalen C, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis. 2007;45:450-8. doi:10.1086/519936
13. Espinosa LE, Li Z, Gomez Barreto D, Calderon Jaimes E, Rodriguez RS, Sakota V, et al. M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States. J Clin Microbiol. 2003;41:373-8. doi:10.1128/JCM.41.1.373-378.2003
14. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24. doi:10.1016/S0002-9343(97)00160-5
15. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis. 1992;166:374-82. doi:10.1093/infdis/166.2.374
16. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Se-lander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991;88:2668-72. doi:10.1073/pnas.88.7.2668
17. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis. 1993;16:792-800, discussion 1-2. doi:10.1093/clind/16.6.792
18. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 1990;336:1167-71. doi:10.1016/0140-6736(90)92777-F
19. Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis. 2002;34:454-60. doi:10.1086/338466
20. Vlaminckx B, van Pelt W, Schouls L, van Silfhout A, Elzenaar C, Mascini E, et al. Epidemiological features of invasive and noninva-sive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis. 2004;23:434-44. doi:10.1007/s10096-004-1147-z
21. Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhoj P, et al. Variations in emm type among group A strep-tococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol. 2005;43:3101-9. doi:10.1128/JCM.43.7.3101-3109.2005
22. Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G, et al. emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol. 2007;45:2249-56. doi:10.1128/JCM.00513-07
23. Centers for Disease Control and Prevention. Active Bacterial Core surveillance report, Emerging Infections Program Network, group A Streptococcus. 2008-2010. [cited 2011 Feb 1]. http://www.cdc.gov/abcs/reports-findings/surv-reports.html
24. Beres SB, Carroll RK, Shea PR, Sitkiewicz I, Martinez-Gutierrez JC, Low DE, et al. Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A. 2010;107:4371-6. doi:10.1073/pnas.0911295107
25. Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, et al. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J Infect Dis. 2001;183:633-9. doi:10.1086/318543
26. Cockerill FR III, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA. 1997;277:38-43. doi:10.1001/jama.277.1.38
27. Dale JB, Penfound T, Chiang E Y, Long V, Shulman ST, Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol. 2005;12:833-6.
28. Villaseñor-Sierra A, McShan WM, Salmi D, Kaplan EL, Johnson DR, Stevens DL. Variable susceptibility to opsonophagocytosis of group A Streptococcus M-1 strains by human immune sera. J Infect Dis. 1999;180:1921-8. doi:10.1086/315120
29. de Malmanche SA, Martin DR. Protective immunity to the group A Streptococcus may be only strain specifi c. Med Microbiol Immunol (Berl). 1994;183:299-306.
30. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA. Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A. 1981;78:4689-93. doi:10.1073/pnas.78.8.4689
31. McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, Ghosh P. Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science. 2008;319:1405-8. doi:10.1126/science.1154470
32. Johnsson E, Thern A, Dahlback B, Heden LO, Wikstrom M, Lin-dahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol. 1996;157:3021-9.
33. Johnsson E, Berggard K, Kotarsky H, Hellwage J, Zipfel PF, Sjo-bring U, et al. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol. 1998;161:4894-901.